Pentoxifylline as adjunctive therapy in cognitive deficits and symptoms of schizophrenia: A randomized double-blind placebo-controlled clinical trial

Background: Due to the inflammatory factors in the pathophysiology of schizophrenia, Pentoxifylline, as anti-inflammatory medication, seems to improve the symptoms of schizophrenia. This study aims to evaluate the efficacy of Pentoxifylline as an adjunctive therapy on cognitive deficits and symptoms...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of psychopharmacology (Oxford) 2023-10, Vol.37 (10), p.1003-1010
Hauptverfasser:	Sinichi, Farideh, Farid Hosseini, Farhad, Fayyazi-Bordbar, Mohammadreza, Sinichi, Mohaddeseh, Jamali, Jamshid, Mohammadpour, Amirhooshang
Format:	Artikel
Sprache:	eng
Schlagworte:	Auditory discrimination learning Chi-square test Clinical trials Cognitive ability Double-blind studies Inflammation Mental disorders Patients Placebos Schizophrenia Statistical analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!